Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07124611 · ClinicalTrials.gov registry record · NA
A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer
A NA study of Stage IIA Pancreatic Cancer AJCC v8 and Stage I Pancreatic Cancer AJCC v8, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07124611 is a NA study of Stage IIA Pancreatic Cancer AJCC v8 and Stage I Pancreatic Cancer AJCC v8 that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 60 participants, above the 50-participant average among 7 other Stage IIA Pancreatic Cancer AJCC v8 trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07124611, a NA study of Stage IIA Pancreatic Cancer AJCC v8 and Stage I Pancreatic Cancer AJCC v8, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial tests how well a psychosocial oncology intervention during neoadjuvant therapy works for patients with pancreatic cancer that has not spread to other parts of the body (localized). Chemotherapy and/or radiation therapy is often recommended prior to surgeryf or patients with pancreatic cancer; this is known as neoadjuvant therapy (NT). The primary advantages of NT include: reducing the size of the cancer mass and/or reducing the spread of cancer, to improve the likelihood of getting all the cancer during surgery, and because receiving chemotherapy after pancreas surgery can be challenging. Other research has shown that NT can lead to improved survival and a lower rate of the cancer returning. Despite these positive effects, NT can be associated with significant physical and emotional side effects. To prepare patients for future surgery and maintain health during chemotherapy and/or radiation, prehabilitation is often recommended. This can include nutritional and physical therapy to help with physical health. An oncology (cancer) psychosocial intervention during NT may be feasible and helpful to patients with localized pancreatic cancer.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Interview
- PROCEDURE Physical Therapy
- PROCEDURE Nutritional Therapy
- BEHAVIORAL Psychosocial Care
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-12-22 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07124611
The ClinicalTrials.gov registry entry for NCT07124611 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 50-participant average among 7 other Stage IIA Pancreatic Cancer AJCC v8 trials with a reported enrollment target (20% higher). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Stage IIA Pancreatic Cancer AJCC v8 appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT07124611 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07124611 about?
NCT07124611 is a clinical study titled "A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer". This clinical trial tests how well a psychosocial oncology intervention during neoadjuvant therapy works for patients with pancreatic cancer that has not spread to other parts of the body (localized). Chemotherapy and/or radiation therapy is often recommended prior to surgeryf or patients with pancr...
What is the current status of trial NCT07124611?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-12-22. Estimated completion is 2026-12-31.
What conditions does trial NCT07124611 study?
This clinical trial studies the following conditions: Stage IIA Pancreatic Cancer AJCC v8, Stage I Pancreatic Cancer AJCC v8, Stage 0 Pancreatic Cancer AJCC v8, Localized Pancreatic Ductal Adenocarcinoma.
What interventions are being tested in trial NCT07124611?
The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER), Physical Therapy (PROCEDURE), Nutritional Therapy (PROCEDURE), Psychosocial Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT07124611?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07124611 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IIA Pancreatic Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
RECRUITING · Phase 2
-
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
RECRUITING · Phase 2
-
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
ACTIVE NOT RECRUITING · Phase 1
-
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Stage IIA Pancreatic Cancer AJCC v8
All registered trials for this condition
Stage I Pancreatic Cancer AJCC v8
All registered trials for this condition
Ohio
All trials with a study site in Ohio
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.